Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from MTA I: Prostate/GU Posters

  • You have access
    The clinical value of whole body Fluorine-18 Fluorodeoxyglucose PET/CT for detecting metastatic bladder cancer
    Zhongyi Yang and Yingjian Zhang
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1408;
  • You have access
    Detection of unexpected prostate cancer with FDG-PET/CT
    Takayoshi Ishimori, Mana Ishibashi, Tsuyoshi Yamada and Yuji Watanabe
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1412;
  • You have access
    [68Ga]Gallium labelled PSMA ligand as new PET-tracer for the diagnosis of prostate cancer: Normal uptake of healthy tissue
    Ali Afshar-Oromieh, Christian Zechmann, Matthias Eder, Michael Eisenhut and Uwe Haberkorn
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1414;
  • You have access
    Assessment of efficacy of [11C]-MeAIB PET/CT as a biomarker of the system A amino acid transport: Comparison with [18F]-FDG and MRI in the patients with prostate cancer
    Tatsuya Higashi, Ryuichi Nishii, Shinya Kagawa, Masaaki Takahashi, Yoshihiko Kishibe, Hiroshi Yamauchi, Satoshi Ishitoya, Hiroyuki Oonishi, Keiichi Kawai and Masato Kobayashi
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1418;
  • You have access
    Bone metastases from prostate cancer: Head-to-head comparison of 99mTc-MDP scintigraphy, 18F-fluorocholine PET/CT, and 18F-fluoride PET/CT
    Poul Høilund-Carlsen, Mads Poulsen, Henrik Petersen, Jørn Jakobsen, Oke Gerke, Jens Karstoft and Steen Walter
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1422;
  • You have access
    Usefulness of positron emission tomography (PET/CT) with 18F-FDG in patients with malignant testicular germ cells tumour
    Hugo Lavados, Rossana Pruzzo, Horacio Amaral, Arquimides Rodriguez, Francisca Redondo, Alejandra Pizarro, Ivan Pinto and Barbara Monje
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1409;

Pages

  • Previous
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire